Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese populationOriginal paper
What was studied?
This study examined the gut microbial community using 16S rRNA gene sequencing to compare obese and lean populations in Japan. Researchers sequenced the V3-V4 hypervariable regions of 16S rRNA from fecal samples using the Illumina MiSeq II platform. The goal was to characterize how gut microbiota composition differs with obesity status and to identify specific taxa associated with each phenotype.
Who was studied?
The study included 20 Japanese volunteers divided into two groups of 10 obese and 10 lean individuals. The average body mass index was 38.1 kg/m2 in the obese group and 16.6 kg/m2 in the lean group, a statistically significant difference. Fecal samples from these volunteers formed the basis of all microbial community comparisons.
What were the most important findings?
The lean group showed significantly higher Shannon diversity than the obese group, indicating greater microbial richness and evenness. Firmicutes and Fusobacteria were significantly more abundant in obese participants, while the Bacteroidetes abundance and Bacteroidetes/Firmicutes ratio did not differ between groups. At the genus level, Alistipes, Anaerococcus, Corpococcus, Fusobacterium, and Parvimonas were enriched in obese individuals, while Bacteroides, Desulfovibrio, Faecalibacterium, Lachnoanaerobaculum, and Olsenella were enriched in lean individuals. Notably, Faecalibacterium prausnitzii, a species known for anti-inflammatory properties, increased significantly in the lean group, whereas pro-inflammatory species increased in the obese group.
What are the greatest implications of this study?
These findings support a link between reduced gut microbial diversity, a shift toward pro-inflammatory taxa, and obesity in a Japanese population. The enrichment of anti-inflammatory commensals like Faecalibacterium prausnitzii in lean individuals suggests that gut microbial composition may influence inflammatory tone and metabolic health. This work adds population-specific evidence to the broader case that gut microbiota profiling could inform obesity risk assessment or targeted interventions, though causality cannot be established from this comparative design.